135 related articles for article (PubMed ID: 11317661)
1. Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes.
Nicoletti F; Conget I; Di Marco R; Speciale AM; Morìnigo R; Bendtzen K; Gomis R
Diabetologia; 2001 Mar; 44(3):309-11. PubMed ID: 11317661
[TBL] [Abstract][Full Text] [Related]
2. Th1-like dominance in high-risk first-degree relatives of type I diabetic patients.
Karlsson MG; Lawesson SS; Ludvigsson J
Diabetologia; 2000 Jun; 43(6):742-9. PubMed ID: 10907120
[TBL] [Abstract][Full Text] [Related]
3. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumour necrosis factor-alpha in peripheral whole blood of people at high risk of developing type 1 diabetes and people with newly diagnosed type 1 diabetes.
Kretowski A; Myśliwiec J; Szelachowska M; Kinalski M; Kinalska I
Diabetes Res Clin Pract; 2000 Feb; 47(2):81-6. PubMed ID: 10670906
[TBL] [Abstract][Full Text] [Related]
5. The analysis of in vitro transforming growth factor-beta1 (TGF-beta1) production by peripheral blood in overt and pre-clinical type 1 diabetes mellitus.
Kretowski A; Maciej K; Ida K
Immunol Lett; 2000 Feb; 71(2):85-9. PubMed ID: 10714434
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease.
Nicoletti F; Conget I; Di Mauro M; Di Marco R; Mazzarino MC; Bendtzen K; Messina A; Gomis R
Diabetologia; 2002 Aug; 45(8):1107-10. PubMed ID: 12189440
[TBL] [Abstract][Full Text] [Related]
7. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.
Hussain MJ; Peakman M; Gallati H; Lo SS; Hawa M; Viberti GC; Watkins PJ; Leslie RD; Vergani D
Diabetologia; 1996 Jan; 39(1):60-9. PubMed ID: 8720604
[TBL] [Abstract][Full Text] [Related]
9. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
10. In vitro interleukin-13 production by peripheral blood in patients with newly diagnosed insulin-dependent diabetes mellitus and their first degree relatives.
Kretowski A; Myśliwiec J; Kinalska I
Scand J Immunol; 2000 Mar; 51(3):321-5. PubMed ID: 10736103
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 18 and sICAM-1 serum levels in families with type 1 diabetes mellitus.
Mirończuk K; Okruszko A; Wawrusiewicz-Kurylonek N; Kretowski A; Kinalska I; Górska M
Rocz Akad Med Bialymst; 2005; 50():151-4. PubMed ID: 16358956
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes.
Petrich de Marquesini LG; Fu J; Connor KJ; Bishop AJ; McLintock NE; Pope C; Wong FS; Dayan CM
Diabetologia; 2010 Jul; 53(7):1451-60. PubMed ID: 20369219
[TBL] [Abstract][Full Text] [Related]
15. [Plasma levels of interleukin-1beta, interleukin-2 and interleukin-4 in recently diagnosed type 1 diabetic children and their association with beta-pancreatic autoantibodies].
Pérez F; Oyarzún A; Carrasco E; Angel B; Albala C; Santos JL
Rev Med Chil; 2004 Apr; 132(4):413-20. PubMed ID: 15382512
[TBL] [Abstract][Full Text] [Related]
16. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
Decochez K; Truyen I; van der Auwera B; Weets I; Vandemeulebroucke E; de Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Pipeleers DG; Gorus FK;
Diabetologia; 2005 Apr; 48(4):687-94. PubMed ID: 15756536
[TBL] [Abstract][Full Text] [Related]
17. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.
Verge CF; Gianani R; Kawasaki E; Yu L; Pietropaolo M; Jackson RA; Chase HP; Eisenbarth GS
Diabetes; 1996 Jul; 45(7):926-33. PubMed ID: 8666144
[TBL] [Abstract][Full Text] [Related]
18. GAD antibody in multiplex diabetic pedigrees of Chinese.
Chen T; Ren Y; Long Y; Zhang X; Yu H; Tian H
Diabetes Care; 2007 Dec; 30(12):3091-2. PubMed ID: 17878243
[No Abstract] [Full Text] [Related]
19. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM
Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129
[TBL] [Abstract][Full Text] [Related]
20. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
